Skip to main content
Top
Published in: Investigational New Drugs 1/2020

01-02-2020 | Acute Myeloid Leukemia | PRECLINICAL STUDIES

Cytotoxicity of [HuArgI (co)-PEG5000]-induced arginine deprivation to ovarian Cancer cells is autophagy dependent

Authors: Ghenwa Nasreddine, Mirvat El-Sibai, Ralph J. Abi-Habib

Published in: Investigational New Drugs | Issue 1/2020

Login to get access

Summary

In this study, we assess arginine auxotrophy in ovarian cancer cells and attempt to target them using arginine deprivation induced by a pegylated recombinant human Arginase I cobalt [HuArgI (Co)-PEG5000]. Ovarian cancer cells were sensitive to [HuArgI (Co)-PEG5000]-induced arginine deprivation with IC50 values in the low pM range. Addition of excess L-citrulline rescued only one of three cell lines tested, indicating that the majority of cell lines are completely auxotrophic for arginine. The expression pattern of argininosuccinate synthetase (ASS1) confirmed the degree of auxotrophy of ovarian cancer cell lines with completely auxotrophic cells not expressing ASS1 and partially auxotrophic cells expressing the enzyme. Ovarian cancer cell lines were negative for annexinV staining while showing loss of membrane integrity and absence of caspase activation, indicating caspase-independent, non-apoptotic cell death. [HuArgI (Co)-PEG5000]-induced arginine deprivation led to extensive and prolonged activation of autophagy, which proved to be deleterious to cell survival since its inhibition led to a significant decrease in cytotoxicity. This indicates that the activation of autophagy following arginine-deprivation, rather than being protective, mediates cell cytotoxicity leading to death by autophagy.
Literature
4.
go back to reference Stone EM, Glazer ES, Chantranupong L, Cherukuri P, Breece RM, Tierney DL, Curley SA, Iverson BL, Georgiou G (2010 Mar 19) Replacing Mn 2+ with co 2+ in human arginase I enhances cytotoxicity toward l -arginine auxotrophic Cancer cell lines. ACS Chem Biol 5(3):333–342PubMedPubMedCentralCrossRef Stone EM, Glazer ES, Chantranupong L, Cherukuri P, Breece RM, Tierney DL, Curley SA, Iverson BL, Georgiou G (2010 Mar 19) Replacing Mn 2+ with co 2+ in human arginase I enhances cytotoxicity toward l -arginine auxotrophic Cancer cell lines. ACS Chem Biol 5(3):333–342PubMedPubMedCentralCrossRef
6.
go back to reference Kuo MT, Savaraj N, Feun LG (2010 Aug 4) Targeted cellular metabolism for cancer chemotherapy with recombinant arginine-degrading enzymes. Oncotarget. 1(4):246–251PubMedPubMedCentralCrossRef Kuo MT, Savaraj N, Feun LG (2010 Aug 4) Targeted cellular metabolism for cancer chemotherapy with recombinant arginine-degrading enzymes. Oncotarget. 1(4):246–251PubMedPubMedCentralCrossRef
7.
go back to reference Glazer ES, Stone EM, Zhu C, Massey KL, Hamir AN, Curley SA (2011 Jun 1) Bioengineered human arginase I with enhanced activity and stability controls hepatocellular and pancreatic carcinoma xenografts. Transl Oncol 4(3):138–146PubMedPubMedCentralCrossRef Glazer ES, Stone EM, Zhu C, Massey KL, Hamir AN, Curley SA (2011 Jun 1) Bioengineered human arginase I with enhanced activity and stability controls hepatocellular and pancreatic carcinoma xenografts. Transl Oncol 4(3):138–146PubMedPubMedCentralCrossRef
8.
go back to reference Davis FF, Abuchowski A, van Es T, Palczuk NC, Chen R, Savoca K, Wieder K (1978) Enzyme-polyethylene glycol adducts: modified enzymes with unique properties. In: Broun GB, Manecke G, Wingard LB (eds) Enzyme Engineering: Volume 4. Springer US, Boston, MA, pp 169–173CrossRef Davis FF, Abuchowski A, van Es T, Palczuk NC, Chen R, Savoca K, Wieder K (1978) Enzyme-polyethylene glycol adducts: modified enzymes with unique properties. In: Broun GB, Manecke G, Wingard LB (eds) Enzyme Engineering: Volume 4. Springer US, Boston, MA, pp 169–173CrossRef
9.
go back to reference Harris JM, Chess RB (2003 Mar) Effect of pegylation on pharmaceuticals. Nat Rev Drug Discov 2(3):214–221PubMedCrossRef Harris JM, Chess RB (2003 Mar) Effect of pegylation on pharmaceuticals. Nat Rev Drug Discov 2(3):214–221PubMedCrossRef
10.
go back to reference Hernandez CP, Morrow K, Lopez-Barcons LA, Zabaleta J, Sierra R, Velasco C, Cole J, Rodriguez PC (2010 Jun 24) Pegylated arginase I: a potential therapeutic approach in T-ALL. Blood. 115(25):5214–5221PubMedPubMedCentralCrossRef Hernandez CP, Morrow K, Lopez-Barcons LA, Zabaleta J, Sierra R, Velasco C, Cole J, Rodriguez PC (2010 Jun 24) Pegylated arginase I: a potential therapeutic approach in T-ALL. Blood. 115(25):5214–5221PubMedPubMedCentralCrossRef
11.
go back to reference Cheng PN-M, Lam T-L, Lam W-M, Tsui S-M, Cheng AW-M, Lo W-H, Leung YC (2007 Jan 1) Pegylated recombinant human arginase (rhArg-peg5,000mw) inhibits the in vitro and in vivo proliferation of human hepatocellular carcinoma through arginine depletion. Cancer Res 67(1):309–317PubMedCrossRef Cheng PN-M, Lam T-L, Lam W-M, Tsui S-M, Cheng AW-M, Lo W-H, Leung YC (2007 Jan 1) Pegylated recombinant human arginase (rhArg-peg5,000mw) inhibits the in vitro and in vivo proliferation of human hepatocellular carcinoma through arginine depletion. Cancer Res 67(1):309–317PubMedCrossRef
12.
go back to reference Lam TL, Wong GKY, Chong HC, Cheng PNM, Choi SC, Chow TL, Kwok SY, Poon RTP, Wheatley DN, Lo WH, Leung YC (2009 May 8) Recombinant human arginase inhibits proliferation of human hepatocellular carcinoma by inducing cell cycle arrest. Cancer Lett 277(1):91–100PubMedCrossRef Lam TL, Wong GKY, Chong HC, Cheng PNM, Choi SC, Chow TL, Kwok SY, Poon RTP, Wheatley DN, Lo WH, Leung YC (2009 May 8) Recombinant human arginase inhibits proliferation of human hepatocellular carcinoma by inducing cell cycle arrest. Cancer Lett 277(1):91–100PubMedCrossRef
13.
go back to reference Khoury O, Ghazale N, Stone E, El-Sibai M, Frankel AE, Abi-Habib RJ (2015) Human recombinant arginase I (co)-PEG5000 [HuArgI (co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human glioblastoma cells. J Neuro-Oncol 122(1):75–85CrossRef Khoury O, Ghazale N, Stone E, El-Sibai M, Frankel AE, Abi-Habib RJ (2015) Human recombinant arginase I (co)-PEG5000 [HuArgI (co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human glioblastoma cells. J Neuro-Oncol 122(1):75–85CrossRef
14.
go back to reference Tanios R, Bekdash A, Kassab E, Stone E, Georgiou G, Frankel A et al (2013 Nov) Human recombinant arginase I(co)-PEG5000 [HuArgI(co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human acute myeloid leukemia cells. Leuk Res 37(11):1565–1571PubMedCrossRef Tanios R, Bekdash A, Kassab E, Stone E, Georgiou G, Frankel A et al (2013 Nov) Human recombinant arginase I(co)-PEG5000 [HuArgI(co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human acute myeloid leukemia cells. Leuk Res 37(11):1565–1571PubMedCrossRef
16.
17.
go back to reference Zhang N, Qi Y, Wadham C, Wang L, Warren A, Di W et al (2010) FTY720 induces necrotic cell death and autophagy in ovarian cancer cells: A protective role of autophagy. Autophagy. 6(8):1157–1167PubMedCrossRef Zhang N, Qi Y, Wadham C, Wang L, Warren A, Di W et al (2010) FTY720 induces necrotic cell death and autophagy in ovarian cancer cells: A protective role of autophagy. Autophagy. 6(8):1157–1167PubMedCrossRef
19.
go back to reference Cloonan SM, Williams DC (2011) The antidepressants maprotiline and fluoxetine induce Type II autophagic cell death in drug-resistant Burkitt’s lymphoma. Int J Cancer 128(7):1712–1723PubMedCrossRef Cloonan SM, Williams DC (2011) The antidepressants maprotiline and fluoxetine induce Type II autophagic cell death in drug-resistant Burkitt’s lymphoma. Int J Cancer 128(7):1712–1723PubMedCrossRef
20.
go back to reference Changou CA, Chen YR, Xing L, Yen Y, Chuang FY, Cheng RH, Bold RJ, Ann DK, Kung HJ (2014) Arginine starvation-associated atypical cellular death involves mitochondrial dysfunction, nuclear DNA leakage and chromatin autophagy. Proc Natl Acad Sci U S A 111(39):14147–14152PubMedPubMedCentralCrossRef Changou CA, Chen YR, Xing L, Yen Y, Chuang FY, Cheng RH, Bold RJ, Ann DK, Kung HJ (2014) Arginine starvation-associated atypical cellular death involves mitochondrial dysfunction, nuclear DNA leakage and chromatin autophagy. Proc Natl Acad Sci U S A 111(39):14147–14152PubMedPubMedCentralCrossRef
21.
go back to reference Kassab E, Darwish M, Timsah Z, Liu S, Leppla SH, Frankel AE et al (2013) Cytotoxicity of Anthrax Lethal Toxin to Human Acute Myeloid Leukemia Cells Is Nonapoptotic and Dependent on Extracellular Signal-Regulated Kinase ½ Activity. Transl Oncol 6(1):25–32PubMedPubMedCentralCrossRef Kassab E, Darwish M, Timsah Z, Liu S, Leppla SH, Frankel AE et al (2013) Cytotoxicity of Anthrax Lethal Toxin to Human Acute Myeloid Leukemia Cells Is Nonapoptotic and Dependent on Extracellular Signal-Regulated Kinase ½ Activity. Transl Oncol 6(1):25–32PubMedPubMedCentralCrossRef
22.
go back to reference Bekdash A, Darwish M, Timsah Z, Kassab E, Ghanem H, Najjar V, Ghosn M, Nasser S, El-Hajj H, Bazerbachi A, Liu SH, Leppla SH, Frankel AE, Abi-Habib RJ (2015) Phospho-MEK1/2 and uPAR Expression Determine Sensitiv-ity of AML Blasts to a Urokinase-Activated Anthrax Lethal Toxin (PrAgU2/LF). Transl Oncol 8(5):347–357PubMedPubMedCentralCrossRef Bekdash A, Darwish M, Timsah Z, Kassab E, Ghanem H, Najjar V, Ghosn M, Nasser S, El-Hajj H, Bazerbachi A, Liu SH, Leppla SH, Frankel AE, Abi-Habib RJ (2015) Phospho-MEK1/2 and uPAR Expression Determine Sensitiv-ity of AML Blasts to a Urokinase-Activated Anthrax Lethal Toxin (PrAgU2/LF). Transl Oncol 8(5):347–357PubMedPubMedCentralCrossRef
23.
go back to reference Agrawal V, Hee Woo J, Borthakur G, Kantarjian HE, Frankel A (2013) Red Blood Cell-Encapsulated Lasparaginase: Potential Therapy of Patients with Asparagine Synthetase Deficient Acute Myeloid Leukemia. Protein Pept Lett 20(4):392–402PubMed Agrawal V, Hee Woo J, Borthakur G, Kantarjian HE, Frankel A (2013) Red Blood Cell-Encapsulated Lasparaginase: Potential Therapy of Patients with Asparagine Synthetase Deficient Acute Myeloid Leukemia. Protein Pept Lett 20(4):392–402PubMed
24.
go back to reference Müller HJ, Boos J (1998) Use of L-asparaginase in childhood ALL. Crit Rev Oncol Hematol 28(2):97–113PubMedCrossRef Müller HJ, Boos J (1998) Use of L-asparaginase in childhood ALL. Crit Rev Oncol Hematol 28(2):97–113PubMedCrossRef
25.
go back to reference Mussai F, Santo CD, Abu-Dayyeh I, Booth S, Quek L, McEwen-Smith RM et al (2013) Acute myeloid leukaemia creates an arginase-dependent immunosuppressive microenvironment. Blood. 122(5):749–758PubMedPubMedCentralCrossRef Mussai F, Santo CD, Abu-Dayyeh I, Booth S, Quek L, McEwen-Smith RM et al (2013) Acute myeloid leukaemia creates an arginase-dependent immunosuppressive microenvironment. Blood. 122(5):749–758PubMedPubMedCentralCrossRef
26.
go back to reference Yoon C-Y, Shim Y-J, Kim E-H, Lee J-H, Won N-H, Kim J-H et al (2007) Renal cell carcinoma does not express argininosuccinate synthetase and is highly sensitive to arginine deprivation via arginine deiminase. Int J Cancer 120(4):897–905PubMedCrossRef Yoon C-Y, Shim Y-J, Kim E-H, Lee J-H, Won N-H, Kim J-H et al (2007) Renal cell carcinoma does not express argininosuccinate synthetase and is highly sensitive to arginine deprivation via arginine deiminase. Int J Cancer 120(4):897–905PubMedCrossRef
27.
go back to reference Agrawal V, Woo JH, Mauldin JP, Jo C, Stone EM, Georgiou G et al (2012) Cytotoxicity of human recombinant arginase I (Co)-PEG5000 in the presence of supplemental L-citrulline is dependent on decreased argininosuccinate synthetase expression in human cells. Anti-Cancer Drugs 23(1):51–64PubMedCrossRef Agrawal V, Woo JH, Mauldin JP, Jo C, Stone EM, Georgiou G et al (2012) Cytotoxicity of human recombinant arginase I (Co)-PEG5000 in the presence of supplemental L-citrulline is dependent on decreased argininosuccinate synthetase expression in human cells. Anti-Cancer Drugs 23(1):51–64PubMedCrossRef
28.
go back to reference Delage B, Fennell DA, Nicholson L, McNeish I, Lemoine NR, Crook T et al (2010) Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer. Int J Cancer 126(12):2762–2772PubMed Delage B, Fennell DA, Nicholson L, McNeish I, Lemoine NR, Crook T et al (2010) Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer. Int J Cancer 126(12):2762–2772PubMed
29.
go back to reference Kim RH, Coates JM, Bowles TL, McNerney GP, Sutcliffe J, Jung JU et al (2009) Arginine Deiminase as a Novel Therapy for Prostate Cancer Induces Autophagy and Caspase-Independent Apoptosis. Cancer Res 69(2):700–708PubMedPubMedCentralCrossRef Kim RH, Coates JM, Bowles TL, McNerney GP, Sutcliffe J, Jung JU et al (2009) Arginine Deiminase as a Novel Therapy for Prostate Cancer Induces Autophagy and Caspase-Independent Apoptosis. Cancer Res 69(2):700–708PubMedPubMedCentralCrossRef
30.
go back to reference Syed N, Langer J, Janczar K, Singh P, Nigro CL, Lattanzio L et al (2013) Epigenetic status of argininosuccinate synthe-tase and argininosuccinate lyase modulates autophagy and cell death in glioblastoma. Cell Death Dis 4:e458PubMedPubMedCentralCrossRef Syed N, Langer J, Janczar K, Singh P, Nigro CL, Lattanzio L et al (2013) Epigenetic status of argininosuccinate synthe-tase and argininosuccinate lyase modulates autophagy and cell death in glioblastoma. Cell Death Dis 4:e458PubMedPubMedCentralCrossRef
31.
go back to reference Periyasamy-Thandavan S, Jiang M, Schoenlein P, Dong Z (2009) Autophagy: molecular machinery, regulation, and im-plications for renal pathophysiology. Am J Physiol Renal Physiol 297(2):F244–F256PubMedPubMedCentralCrossRef Periyasamy-Thandavan S, Jiang M, Schoenlein P, Dong Z (2009) Autophagy: molecular machinery, regulation, and im-plications for renal pathophysiology. Am J Physiol Renal Physiol 297(2):F244–F256PubMedPubMedCentralCrossRef
32.
go back to reference Macintosh RL, Timpson P, Thorburn J, Anderson KI, Thorburn A, Ryan KM (2012) Inhibition of autophagy impairs tumor cell invasion in an organotypic model. Cell Cycle 11(10):2022–2029PubMedPubMedCentralCrossRef Macintosh RL, Timpson P, Thorburn J, Anderson KI, Thorburn A, Ryan KM (2012) Inhibition of autophagy impairs tumor cell invasion in an organotypic model. Cell Cycle 11(10):2022–2029PubMedPubMedCentralCrossRef
33.
go back to reference Bean GR, Kremer JC, Prudner BC, Schenone AD, Yao JC, Schultze MB, Chen DY, Tanas MR, Adkins DR, Bomalaski J, Rubin BP, Michel LS, Van Tine BA (2016) A metabolic synthetic lethal strategy with arginine depriva-tion and chloroquine leads to cell death in ASS1-deficient sarcomas. Cell Death Dis 7(10):e2406PubMedPubMedCentralCrossRef Bean GR, Kremer JC, Prudner BC, Schenone AD, Yao JC, Schultze MB, Chen DY, Tanas MR, Adkins DR, Bomalaski J, Rubin BP, Michel LS, Van Tine BA (2016) A metabolic synthetic lethal strategy with arginine depriva-tion and chloroquine leads to cell death in ASS1-deficient sarcomas. Cell Death Dis 7(10):e2406PubMedPubMedCentralCrossRef
34.
go back to reference Lin C, Wang Z, Li L, He Y, Fan J, Liu Z, Zhao S, Ju D (2015) The role of autophagy in the cytotoxicity induced by re-recombinant human arginase in laryngeal squamous cell carcinoma. Appl Microbiol Biotechnol 99(20):8487–8494PubMedCrossRef Lin C, Wang Z, Li L, He Y, Fan J, Liu Z, Zhao S, Ju D (2015) The role of autophagy in the cytotoxicity induced by re-recombinant human arginase in laryngeal squamous cell carcinoma. Appl Microbiol Biotechnol 99(20):8487–8494PubMedCrossRef
35.
go back to reference Delage B, Luong P, Maharaj L, O'Riain C, Syed N, Crook T, Hatzimichael E, Papoudou-Bai A, Mitchell TJ, Whittaker SJ, Cerio R, Gribben J, Lemoine N, Bomalaski J, Li CF, Joel S, Fitzgibbon J, Chen LT, Szlosarek PW (2012) Promoter methylation of argininosuccinate synthetase-1 sensitises lymphomas to arginine deiminase treat-ment, autophagy and caspase-dependent apoptosis. Cell Death Dis 3:e342PubMedPubMedCentralCrossRef Delage B, Luong P, Maharaj L, O'Riain C, Syed N, Crook T, Hatzimichael E, Papoudou-Bai A, Mitchell TJ, Whittaker SJ, Cerio R, Gribben J, Lemoine N, Bomalaski J, Li CF, Joel S, Fitzgibbon J, Chen LT, Szlosarek PW (2012) Promoter methylation of argininosuccinate synthetase-1 sensitises lymphomas to arginine deiminase treat-ment, autophagy and caspase-dependent apoptosis. Cell Death Dis 3:e342PubMedPubMedCentralCrossRef
Metadata
Title
Cytotoxicity of [HuArgI (co)-PEG5000]-induced arginine deprivation to ovarian Cancer cells is autophagy dependent
Authors
Ghenwa Nasreddine
Mirvat El-Sibai
Ralph J. Abi-Habib
Publication date
01-02-2020
Publisher
Springer US
Published in
Investigational New Drugs / Issue 1/2020
Print ISSN: 0167-6997
Electronic ISSN: 1573-0646
DOI
https://doi.org/10.1007/s10637-019-00756-w

Other articles of this Issue 1/2020

Investigational New Drugs 1/2020 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine